MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Nasdaq: MDGL · CIK 0001157601 · United States
Every official MADRIGAL PHARMACEUTICALS, INC. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open MDGL filings
MADRIGAL PHARMACEUTICALS, INC. documents
- MADRIGAL PHARMACEUTICALS, INC. 10-K 2026MDGL 10-K 2026: annual report for fiscal 2026
- MADRIGAL PHARMACEUTICALS, INC. 10-K 2025MDGL 10-K 2025: annual report for fiscal 2025
- MADRIGAL PHARMACEUTICALS, INC. 10-K 2024MDGL 10-K 2024: annual report for fiscal 2024
- MADRIGAL PHARMACEUTICALS, INC. 10-K 2023MDGL 10-K 2023: annual report for fiscal 2023
- MADRIGAL PHARMACEUTICALS, INC. 10-K 2022MDGL 10-K 2022: annual report for fiscal 2022
- MADRIGAL PHARMACEUTICALS, INC. 10-Q 2026MDGL 10-Q 2026: quarterly report for fiscal 2026
- MADRIGAL PHARMACEUTICALS, INC. 10-Q 2025MDGL 10-Q 2025: quarterly report for fiscal 2025
- MADRIGAL PHARMACEUTICALS, INC. 10-Q 2024MDGL 10-Q 2024: quarterly report for fiscal 2024
- MADRIGAL PHARMACEUTICALS, INC. 10-Q 2023MDGL 10-Q 2023: quarterly report for fiscal 2023
- MADRIGAL PHARMACEUTICALS, INC. 10-Q 2022MDGL 10-Q 2022: quarterly report for fiscal 2022
- MADRIGAL PHARMACEUTICALS, INC. 8-K 2026MDGL 8-K 2026: current report for fiscal 2026
- MADRIGAL PHARMACEUTICALS, INC. 8-K 2025MDGL 8-K 2025: current report for fiscal 2025
- MADRIGAL PHARMACEUTICALS, INC. 8-K 2024MDGL 8-K 2024: current report for fiscal 2024
- MADRIGAL PHARMACEUTICALS, INC. 8-K 2023MDGL 8-K 2023: current report for fiscal 2023
- MADRIGAL PHARMACEUTICALS, INC. 8-K 2022MDGL 8-K 2022: current report for fiscal 2022
- MADRIGAL PHARMACEUTICALS, INC. DEF 14A 2026MDGL DEF 14A 2026: proxy statement for fiscal 2026
- MADRIGAL PHARMACEUTICALS, INC. DEF 14A 2025MDGL DEF 14A 2025: proxy statement for fiscal 2025
- MADRIGAL PHARMACEUTICALS, INC. DEF 14A 2024MDGL DEF 14A 2024: proxy statement for fiscal 2024
- MADRIGAL PHARMACEUTICALS, INC. DEF 14A 2023MDGL DEF 14A 2023: proxy statement for fiscal 2023
- MADRIGAL PHARMACEUTICALS, INC. DEF 14A 2022MDGL DEF 14A 2022: proxy statement for fiscal 2022
- MADRIGAL PHARMACEUTICALS, INC. Form 4 2026MDGL Form 4 2026: insider trading filing for fiscal 2026
- MADRIGAL PHARMACEUTICALS, INC. Form 4 2025MDGL Form 4 2025: insider trading filing for fiscal 2025
- MADRIGAL PHARMACEUTICALS, INC. Form 4 2024MDGL Form 4 2024: insider trading filing for fiscal 2024
- MADRIGAL PHARMACEUTICALS, INC. Form 4 2023MDGL Form 4 2023: insider trading filing for fiscal 2023
- MADRIGAL PHARMACEUTICALS, INC. Form 4 2022MDGL Form 4 2022: insider trading filing for fiscal 2022
- MADRIGAL PHARMACEUTICALS, INC. S-1 2026MDGL S-1 2026: registration statement for fiscal 2026
- MADRIGAL PHARMACEUTICALS, INC. S-1 2025MDGL S-1 2025: registration statement for fiscal 2025
- MADRIGAL PHARMACEUTICALS, INC. S-1 2024MDGL S-1 2024: registration statement for fiscal 2024
- MADRIGAL PHARMACEUTICALS, INC. S-1 2023MDGL S-1 2023: registration statement for fiscal 2023
- MADRIGAL PHARMACEUTICALS, INC. S-1 2022MDGL S-1 2022: registration statement for fiscal 2022
- MADRIGAL PHARMACEUTICALS, INC. 13F 2026MDGL 13F 2026: institutional holdings for fiscal 2026
- MADRIGAL PHARMACEUTICALS, INC. 13F 2025MDGL 13F 2025: institutional holdings for fiscal 2025
- MADRIGAL PHARMACEUTICALS, INC. 13F 2024MDGL 13F 2024: institutional holdings for fiscal 2024
- MADRIGAL PHARMACEUTICALS, INC. 13F 2023MDGL 13F 2023: institutional holdings for fiscal 2023
- MADRIGAL PHARMACEUTICALS, INC. 13F 2022MDGL 13F 2022: institutional holdings for fiscal 2022
More companies